<- Go Home
Worldwide Biotech & Pharmaceutical Company
Worldwide Biotech & Pharmaceutical Company, a biotech company, develops and markets viruses/viral vectors, external diagnostic reagents, prophylactic vaccines, and oral solid dosage forms for humans in China and Southeast Asia. It offers products for hepatitis C virus, diagnostic medicines, and over-the-counter drugs. The company works with pharmaceutical research institutes, and establishes connections with central and local governments. Worldwide Biotech & Pharmaceutical Company was founded in 2001 and is headquartered in Xi'an, China.
Market Cap
$377.4K
Volume
11.6K
Cash and Equivalents
$98.1K
EBITDA
-$647.1K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$93.4K
Profit Margin
1060.59%
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.12
Price / Earnings
-0.33
Price / Tangible Book Value
-0.10
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.1M
Return on Equity
48.16%
Return on Assets
-12.46
Cash and Short Term Investments
$98.1K
Debt
$3.5M
Equity
-$3.7M
Revenue
$8.8K
Unlevered FCF
$2.7M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium